Niquitin Tropische Früchte (Nicotine Resinate)

Nicotine resinate, the active ingredient in Niquitin Tropische Früchte, is a nicotine replacement therapy presented as an oromucosal formulation for oral mucosal use. It is intended to help adults reduce nicotine withdrawal symptoms and support smoking cessation.

GNH USA supplies Niquitin Tropische Früchte as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Nicotine resinate is used in nicotine replacement therapy to aid smoking cessation.

- Smoking cessation: helps reduce cravings and withdrawal symptoms in adults trying to quit tobacco use. - Tobacco dependence: supports gradual reduction of nicotine intake for individuals dependent on nicotine. - Relapse prevention: assists former smokers in maintaining abstinence by providing controlled nicotine exposure.

Adverse reactions may occur with oromucosal nicotine replacement products.

Common Side Effects: - Mouth irritation: mild soreness or tingling in the oral cavity. - Throat irritation: discomfort or scratchy sensation in the throat. - Nausea: transient feeling of queasiness. - Hiccups: brief, involuntary diaphragm contractions. - Dizziness: light‑headed sensation, especially when standing quickly. - Headache: mild to moderate pain.

Serious or Rare Side Effects: - Allergic reaction: rash, swelling, or anaphylaxis requiring immediate medical attention. - Severe mouth ulceration: persistent ulcerative lesions in the oral mucosa. - Cardiovascular events: increased heart rate, hypertension, or chest pain. - Respiratory difficulty: shortness of breath or wheezing. - Persistent vomiting: inability to retain oral intake. - Syncope: fainting episodes.

Before using Niquitin Tropische Früchte, consider the following safety measures.

- Assess nicotine dependence level: determine appropriate therapy based on user’s smoking history. - Avoid use in recent myocardial infarction patients: consult a physician before starting. - Do not combine with other nicotine products: risk of nicotine overdose. - Pregnancy and breastfeeding: discuss potential risks with a healthcare professional. - Store at ambient temperature: keep in the original pack, protect from moisture and heat.

Nicotine resinate may interact with other medicines; monitor patients accordingly.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): may increase cardiovascular risk. - Other nicotine replacement products: risk of excessive nicotine exposure.

Moderate Interactions (Monitor Closely): - CYP2A6 inhibitors: may alter nicotine metabolism and increase plasma levels. - Antidepressants (SSRIs): monitor for heightened side effects such as nausea. - Antihypertensive agents: nicotine may reduce their efficacy, requiring blood pressure monitoring.